Jason P. Izard

Urology
1959 NE Pacific St
Seattle, WA 98195

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications

2025 Canadian Urological Association Expert Report: Muscle-invasive bladder cancer.

2025 Canadian Urological Association Expert Report: Muscle-invasive bladder cancer.

Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada
Published: February 03, 2025

Patient information resources: Bridging the communication gaps.

Patient information resources: Bridging the communication gaps.

Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada
Published: April 22, 2024

Addressing controversial areas in the management of advanced prostate cancer in Canada Areas of consensus and controversy from the third Canadian consensus forum.

Addressing controversial areas in the management of advanced prostate cancer in Canada Areas of consensus and controversy from the third Canadian consensus forum.

Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada
Published: February 21, 2024

Diagnosis, Management, and Follow-Up of the Incidentally Discovered Adrenal Mass: CUA Guideline Endorsed by the AUA.

Diagnosis, Management, and Follow-Up of the Incidentally Discovered Adrenal Mass: CUA Guideline Endorsed by the AUA.

Journal: The Journal of urology
Published: August 09, 2023

Canadian Urological Association guideline: Diagnosis, management, and followup of the incidentally discovered adrenal mass.

Canadian Urological Association guideline: Diagnosis, management, and followup of the incidentally discovered adrenal mass.

Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada
Published: February 27, 2023

Testicular cancer survivorship: Long-term toxicity and management.

Testicular cancer survivorship: Long-term toxicity and management.

Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada
Published: July 29, 2022

UPDATE - Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies Summary of changes.

UPDATE - Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies Summary of changes.

Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada
Published: July 29, 2022

UPDATE - Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies.

UPDATE - Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies.

Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada
Published: July 29, 2022

Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies - Executive summary.

Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies - Executive summary.

Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada
Published: June 15, 2021

Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies.

Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies.

Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada
Published: June 15, 2021

Results from a Canadian consensus forum of key controversial areas in the management of advanced prostate cancer: Recommendations for Canadian healthcare providers.

Results from a Canadian consensus forum of key controversial areas in the management of advanced prostate cancer: Recommendations for Canadian healthcare providers.

Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada
Published: June 14, 2021

Treatment and Patient Selection for Patients with Metastatic Castration-resistant Prostate After Progression on Docetaxel and Abiraterone/Enzalutamide: When to Play Your CARD and When to Do Your PARP.

Treatment and Patient Selection for Patients with Metastatic Castration-resistant Prostate After Progression on Docetaxel and Abiraterone/Enzalutamide: When to Play Your CARD and When to Do Your PARP.

Journal: European urology
Published: January 12, 2021
Showing 1-12 of 45

Last Updated: 09/26/2026